|
Heinrich, Michael C |
Oregon Health & Science University |
Novel models for functional profiling of germline SDH variants associated with cancer |
|
PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies |
|
Herman, James G. |
University Of Pittsburgh At Pittsburgh |
Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer |
Early Detection Research Network |
RFA-CA-16-009: The Early Detection Research Network: Biomarker Developmental Laboratories |
|
Hirsch, Fred R |
Icahn School Of Medicine At Mount Sinai |
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses |
COVID Serology |
RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence |
|
Hitchins, Megan P |
Cedars-Sinai Medical Center |
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age |
|
PA-20-185: NIH Research Project Grant |
|
Hollingsworth, Michael A. |
University Of Nebraska Medical Center |
Pancreatic Cancer Detection Consortium |
Pancreatic Cancer Detection Consortium |
PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units |
|
Houghton, A Mcgarry |
Fred Hutchinson Cancer Center |
Tumor-specific autoantibodies for SCLC early detection |
|
PA-19-056: Research Project Grant |
|
Hur, Chin |
Columbia University Health Sciences |
Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype |
|
PA-20-185: NIH Research Project Grant |
|
Iagaru, Andrei |
Stanford University |
Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma |
Pancreatic Cancer Detection Consortium |
PAR-15-289: The Pancreatic Cancer Detection Consortium |
|
Ibsen, Stuart D. |
Oregon Health & Science University |
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers |
|
PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection |
|
Ibsen, Stuart D. |
Oregon Health & Science University |
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers |
|
PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection |
|
Ivanov, Alexander R. |
Northeastern University |
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection |
|
PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
|
Iyer, Prasad G. |
Mayo Clinic Rochester |
Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma |
|
PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program |
|
Jiang, Feng |
University Of Maryland Baltimore |
Plasma biomarkers for lung cancer diagnosis |
|
PAR-18-317: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) |
|
Kalluri, Raghu |
University Of Tx Md Anderson Can Ctr |
Rigorous and reproducible mutational analysis of the urinary exosomal DNA |
|
PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection |
|
Kanwal, Fasiha |
Baylor College Of Medicine |
Risk Stratification for and Early Detection of Liver Cancer |
Translational Liver Consortium |
RFA-CA-17-025: Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01) |
